Colchicine 0.5 mg for pulmonary fibrosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Mar 2021: Trial started, NCT04818489
  2. 26 Mar 2021: Trial registered, NCT04818489

The trials

NCT04818489: Colchicine and Post-COVID-19 Pulmonary Fibrosis

State
State not given
Phase
Phase 4
People
260 taking part
Started
25 Mar 2021
Primary completion
25 Aug 2021
Arms
Colchicine group
Results
None posted
  1. 25 Mar 2021: Trial started
  2. 26 Mar 2021: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.